Summitry LLC’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.7M Sell
1,423,307
-42,519
-3% -$1.35M 1.34% 23
2026
Q1
$46.1M Sell
1,465,826
-10,131
-0.7% -$319K 1.63% 18
2025
Q4
$43.5M Buy
1,475,957
+25,170
+2% +$699K 1.81% 21
2025
Q3
$36.6M Buy
1,450,787
+303,332
+26% +$7.39M 1.55% 25
2025
Q2
$27.5M Buy
+1,147,455
New +$26.6M 1.25% 32

Other funds holding RTO

Summitry LLC's RTO Position: Q2 2026 in Review

Summitry LLC reduced its Rentokil (RTO) stake by 2.9% in Q2 2026, selling an estimated $1.35M and leaving 1,423,307 shares worth $40.7M. The position accounts for 1.34% of the portfolio, ranked #23.

Summitry LLC first reported a position in RTO in Q2 2025 and has held it in 5 quarters since. The position peaked at $46.1M in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Summitry LLC held 1,423,307 shares of Rentokil worth $40.7M as of Q2 2026.
  • Summitry LLC sold 42,519 Rentokil shares in Q2 2026, an estimated $1.35M.
  • Rentokil made up 1.34% of Summitry LLC's portfolio in Q2 2026, its #23 holding.
  • Summitry LLC first reported a position in Rentokil in Q2 2025 and has held it in 5 quarters since.
  • Summitry LLC's Rentokil position peaked at $46.1M in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.